-
Chemoimmunotherapy is
chemotherapy combined with immunotherapy.
Chemotherapy uses
different drugs to kill or slow the
growth of
cancer cells; immunotherapy...
- to first-line
chemoimmunotherapy or
relapse within 12
months of first-line
chemoimmunotherapy; or
disease to first-line
chemoimmunotherapy or
relapse after...
-
Pathologic Response in
Patients with
NSCLC Receiving Neoadjuvant Chemoimmunotherapy".
Clinical Cancer Research. 27 (21): 5878–5890. doi:10.1158/1078-0432...
-
those with
significant symptoms, chemotherapy, immunotherapy, or
chemoimmunotherapy may be used.
Depending on the individual's age,
physical condition...
- Stephan; Webb, David; Janka, Gritta; Henter, Jan-Inge (2011-10-27). "
Chemoimmunotherapy for
hemophagocytic lymphohistiocytosis: long-term
results of the HLH-94...
- that is
refractory to first-line
chemoimmunotherapy or
relapses within twelve months of first-line
chemoimmunotherapy. It is not
indicated for the treatment...
-
pneumonitis development in non-small-cell lung
cancer patients receiving chemoimmunotherapy from
NADIM trial".
Journal for
Immunotherapy of Cancer. 9 (8): e002804...
-
absence of 17p
deletion or TP53
mutation in
adults who have
failed both
chemoimmunotherapy and a B cell
receptor pathway inhibitor.
Venetoclax is also indicated...
- I-II
study of the
histone deacetylase inhibitor valproic acid plus
chemoimmunotherapy in
patients with
advanced melanoma".
British Journal of Cancer. 100...
-
diagnosed with
diffuse large B-cell lymphoma, and said he
would undergo chemoimmunotherapy,
which he
completed in
April 2023. On
April 27, he said the cancer...
